---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-303169"
form_type: "8-K"
ticker: "KMTS"
cik: "0001877184"
company_name: "KESTRA MEDICAL TECHNOLOGIES, LTD."
filed_at: "2026-07-14T20:08:33+00:00"
generated_at: "2026-07-14T20:11:23.772908+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Kestra Medical reports Q4 revenue $28.6M (+66% YoY); secures $200M loan facility

## Summary
- Q4 FY2026 revenue $28.6M (+66% YoY); FY revenue $95.1M (+59% YoY); FY27 guidance $137M (+44%).
- Gross margin expanded to 54.8% in Q4 (vs 44.3% prior year); FY margin 51.4% (vs 40.5%).
- GAAP net loss Q4 $38.8M, FY $131.6M; adjusted EBITDA loss Q4 $26.7M, FY $87.0M.
- Entered $200M senior secured loan facility; drew $75M Tranche A on July 10, 2026; net proceeds ~$20M after repaying prior loan.
- Loan matures July 10, 2031; interest SOFR+5.50% (floor 3.25%); 48 months interest-only; minimum liquidity $20M.

## SEC filing metadata
- accession: 0001193125-26-303169
- form_type: 8-K
- ticker: KMTS
- cik: 0001877184
- company_name: KESTRA MEDICAL TECHNOLOGIES, LTD.
- filed_at: 2026-07-14T20:08:33+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 1.02, 2.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1877184/000119312526303169/0001193125-26-303169-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1877184/000119312526303169/ck0001877184-20260710.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-303169
- JSON: https://secwatch.observer/filing/0001193125-26-303169.json
- Plain text: https://secwatch.observer/filing/0001193125-26-303169.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.